392 related articles for article (PubMed ID: 33430702)
1. Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn's disease.
Wang Y; Gao X; Zhang X; Xiao F; Hu H; Li X; Dong F; Sun M; Xiao Y; Ge T; Li D; Yu G; Liu Z; Zhang T
Gut Microbes; 2021; 13(1):1-18. PubMed ID: 33430702
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of Faecal Microbiota in Paediatric Crohn's Disease and Their Dynamic Changes During Infliximab Therapy.
Wang Y; Gao X; Ghozlane A; Hu H; Li X; Xiao Y; Li D; Yu G; Zhang T
J Crohns Colitis; 2018 Feb; 12(3):337-346. PubMed ID: 29194468
[TBL] [Abstract][Full Text] [Related]
3. Fecal Microbiota Alterations Associated With Clinical and Endoscopic Response to Infliximab Therapy in Crohn's Disease.
Zhuang X; Tian Z; Feng R; Li M; Li T; Zhou G; Qiu Y; Chen B; He Y; Chen M; Zeng Z; Zhang S
Inflamm Bowel Dis; 2020 Oct; 26(11):1636-1647. PubMed ID: 33026078
[TBL] [Abstract][Full Text] [Related]
4. The impact of exclusive enteral nutrition on the gut microbiome and bile acid metabolism in pediatric Crohn's disease.
Lv Y; Lou Y; Liu A; Cheng Q; Yang G; Xu C; Luo Y; Lou J; Yu J; Fang Y; Zhao H; Peng K; Ni Y; Chen J
Clin Nutr; 2023 Feb; 42(2):116-128. PubMed ID: 36527826
[TBL] [Abstract][Full Text] [Related]
5. Bacterial and Fungal Profiles as Markers of Infliximab Drug Response in Inflammatory Bowel Disease.
Ventin-Holmberg R; Eberl A; Saqib S; Korpela K; Virtanen S; Sipponen T; Salonen A; Saavalainen P; Nissilä E
J Crohns Colitis; 2021 Jun; 15(6):1019-1031. PubMed ID: 33300552
[TBL] [Abstract][Full Text] [Related]
6. The relationship between fecal bile acids and microbiome community structure in pediatric Crohn's disease.
Connors J; Dunn KA; Allott J; Bandsma R; Rashid M; Otley AR; Bielawski JP; Van Limbergen J
ISME J; 2020 Mar; 14(3):702-713. PubMed ID: 31796936
[TBL] [Abstract][Full Text] [Related]
7. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
Takahashi K; Nishida A; Fujimoto T; Fujii M; Shioya M; Imaeda H; Inatomi O; Bamba S; Sugimoto M; Andoh A
Digestion; 2016; 93(1):59-65. PubMed ID: 26789999
[TBL] [Abstract][Full Text] [Related]
8. Bacterial Taxa and Functions Are Predictive of Sustained Remission Following Exclusive Enteral Nutrition in Pediatric Crohn's Disease.
Jones CMA; Connors J; Dunn KA; Bielawski JP; Comeau AM; Langille MGI; Van Limbergen J
Inflamm Bowel Dis; 2020 Jun; 26(7):1026-1037. PubMed ID: 31961432
[TBL] [Abstract][Full Text] [Related]
9. Exclusive enteral nutrition mediates gut microbial and metabolic changes that are associated with remission in children with Crohn's disease.
Diederen K; Li JV; Donachie GE; de Meij TG; de Waart DR; Hakvoort TBM; Kindermann A; Wagner J; Auyeung V; Te Velde AA; Heinsbroek SEM; Benninga MA; Kinross J; Walker AW; de Jonge WJ; Seppen J
Sci Rep; 2020 Nov; 10(1):18879. PubMed ID: 33144591
[TBL] [Abstract][Full Text] [Related]
10. Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's Disease.
Beltrán B; Iborra M; Sáez-González E; Marqués-Miñana MR; Moret I; Cerrillo E; Tortosa L; Bastida G; Hinojosa J; Poveda-Andrés JL; Nos P
Dig Dis; 2019; 37(2):108-115. PubMed ID: 30149385
[TBL] [Abstract][Full Text] [Related]
11. The pathophysiology of bile acid diarrhoea: differences in the colonic microbiome, metabolome and bile acids.
Sagar NM; Duboc H; Kay GL; Alam MT; Wicaksono AN; Covington JA; Quince C; Kokkorou M; Svolos V; Palmieri LJ; Gerasimidis K; Walters JRF; Arasaradnam RP
Sci Rep; 2020 Nov; 10(1):20436. PubMed ID: 33235223
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis.
Chen W; Wei Y; Xiong A; Li Y; Guan H; Wang Q; Miao Q; Bian Z; Xiao X; Lian M; Zhang J; Li B; Cao Q; Fan Z; Zhang W; Qiu D; Fang J; Gershwin ME; Yang L; Tang R; Ma X
Clin Rev Allergy Immunol; 2020 Feb; 58(1):25-38. PubMed ID: 30900136
[TBL] [Abstract][Full Text] [Related]
13. Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease.
Shaw KA; Bertha M; Hofmekler T; Chopra P; Vatanen T; Srivatsa A; Prince J; Kumar A; Sauer C; Zwick ME; Satten GA; Kostic AD; Mulle JG; Xavier RJ; Kugathasan S
Genome Med; 2016 Jul; 8(1):75. PubMed ID: 27412252
[TBL] [Abstract][Full Text] [Related]
14. Co-occurrence of gut microbiota dysbiosis and bile acid metabolism alteration is associated with psychological disorders in Crohn's disease.
Feng L; Zhou N; Li Z; Fu D; Guo Y; Gao X; Liu X
FASEB J; 2022 Jan; 36(1):e22100. PubMed ID: 34939244
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory Gut Microbial Pathways Are Decreased During Crohn's Disease Exacerbations.
Klaassen MAY; Imhann F; Collij V; Fu J; Wijmenga C; Zhernakova A; Dijkstra G; Festen EAM; Gacesa R; Vich Vila A; Weersma RK
J Crohns Colitis; 2019 Oct; 13(11):1439-1449. PubMed ID: 31066440
[TBL] [Abstract][Full Text] [Related]
16. Detection of Gut Dysbiosis due to Reduced Clostridium Subcluster XIVa Using the Fecal or Serum Bile Acid Profile.
Murakami M; Iwamoto J; Honda A; Tsuji T; Tamamushi M; Ueda H; Monma T; Konishi N; Yara S; Hirayama T; Miyazaki T; Saito Y; Ikegami T; Matsuzaki Y
Inflamm Bowel Dis; 2018 Apr; 24(5):1035-1044. PubMed ID: 29688473
[TBL] [Abstract][Full Text] [Related]
17. Fecal microbiota and metabolites are distinct in a pilot study of pediatric Crohn's disease patients with higher levels of perceived stress.
Mackner LM; Hatzakis E; Allen JM; Davies RH; Kim SC; Maltz RM; Bailey MT
Psychoneuroendocrinology; 2020 Jan; 111():104469. PubMed ID: 31654986
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Active Crohn's Disease With an Ordinary Food-based Diet That Replicates Exclusive Enteral Nutrition.
Svolos V; Hansen R; Nichols B; Quince C; Ijaz UZ; Papadopoulou RT; Edwards CA; Watson D; Alghamdi A; Brejnrod A; Ansalone C; Duncan H; Gervais L; Tayler R; Salmond J; Bolognini D; Klopfleisch R; Gaya DR; Milling S; Russell RK; Gerasimidis K
Gastroenterology; 2019 Apr; 156(5):1354-1367.e6. PubMed ID: 30550821
[TBL] [Abstract][Full Text] [Related]
19. Altered profiles of fecal bile acids correlate with gut microbiota and inflammatory responses in patients with ulcerative colitis.
Yang ZH; Liu F; Zhu XR; Suo FY; Jia ZJ; Yao SK
World J Gastroenterol; 2021 Jun; 27(24):3609-3629. PubMed ID: 34239273
[TBL] [Abstract][Full Text] [Related]
20. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
Chen R; Wang J; Zhan R; Zhang L; Wang X
J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
